Skip to main content

BLRX · BioLineRx Ltd. · Analyst Estimates

Track BLRX — free
$2.28 -0.09 (-3.80%)
Market Cap
$11.75M
Shares
4.98M
Volume · Oct 5 20.26K Avg daily vol (3M) 19.18K

Analyst Estimates

Compare analyst forecasts for BioLineRx Ltd. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 22:46 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-3.14
-3.14
-3.14
—
0.0
-0.93
0.0
-0.93
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
1500000
1620500
1741000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.52
-2.52
-2.52
—
0.0
-0.64
0.0
-0.64
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
1942000
2221000
2500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.77
-0.77
-0.77
—
0.0
-0.18
0.0
-0.18
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
340000
357500
375000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.8
-0.8
-0.8
—
0.0
-0.18
0.0
-0.18
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
390000
492500
595000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —
Key facts CIK 1498403 CUSIP 09071M304 Visit website Investor relations